Creative Biolabs-Immuno-oncology

Anti-XPNPEP2 (clone 1G2E2E) SynExpress la-Cy3-cJ-K Modified CD8+ T cells (CAT#: ITS-1224-CR2058)

DatasheetDatasheet
Description
This product utilizes Modified CD8+ T cells that have been engineered with our proprietary GeneCircuit technology to specifically target XPNPEP2 (clone 1G2E2E). We employs the AAV (lac-Cy3-c-Jun-KpnI) vector components and the SynExpress system of the lncRNA Base Editing/Negative feedback for a robust and sustained response against cancers.
Host
Mouse
Target
XPNPEP2
Clone
1G2E2E
Species Reactivity
Human
Cell Source
Modified CD8+ T cells
Sensor Gene
Cy3
Promoter
lac
Effector Gene
c-Jun
Insertion Sites
KpnI
Gene Modification
Base Editing
Modification Domain
lncRNA
Carrier Type
AAV
Transformation Accuracy
0.86
Cell Culture
Suspension Culture
Related Products

For Research Use Only | Not For Clinical Use

Online Inquiry
Copyright © 2026 Creative Biolabs. All Rights Reserved.
ISO 9001 Certified - Creative Biolabs Quality Management System.